Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.23.1
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock - Number of Shares, Shares Issued
Common Stock - Number of Shares, Treasury Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period at Dec. 31, 2021 $ 643,417 $ 33 $ (125,753) $ 580,796 $ (8,443) $ 196,784
Beginning balance, shares issued (shares) at Dec. 31, 2021   33,603,839        
Beginning balance, treasury stock (shares) at Dec. 31, 2021     (3,196,578)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2021   30,407,261        
Restricted stock awards, net of forfeitures (shares)   66,358        
Share-based compensation expense 541     541    
Restricted stock surrendered due to employee tax liability (134)   $ (134)      
Restricted stock surrendered due to employee tax liability (shares)   (5,161) (5,161)      
Cash dividends declared (common stock, $0.22/share, $0.25/share) (6,691)         (6,691)
Net income 20,695         20,695
Change in unrealized gain (loss) on securities available for sale, net of income taxes (36,376)       (36,376)  
Balance at end of period at Mar. 31, 2022 621,452 $ 33 $ (125,887) 581,337 (44,819) 210,788
Ending balance, shares issued (shares) at Mar. 31, 2022   33,670,197        
Ending balance, treasury stock (shares) at Mar. 31, 2022     (3,201,739)      
Ending balance, shares outstanding (shares) at Mar. 31, 2022   30,468,458        
Balance at beginning of period at Dec. 31, 2022 $ 637,515 $ 33 $ (126,485) 583,410 (88,985) 269,542
Beginning balance, shares issued (shares) at Dec. 31, 2022   33,708,234        
Beginning balance, treasury stock (shares) at Dec. 31, 2022 (3,222,613)   (3,222,613)      
Beginning balance, shares outstanding (shares) at Dec. 31, 2022   30,485,621        
Stock options exercised $ (181)   $ (1,003) 822    
Stock options exercised (shares)   50,000        
Stock options exercised, treasury stock (shares)     (35,273)      
Stock options exercised, shares outstanding (shares)   14,727        
Restricted stock awards, net of forfeitures (shares)   69,567        
Share-based compensation expense 652     652    
Restricted stock surrendered due to employee tax liability (40)   $ (40)      
Restricted stock surrendered due to employee tax liability (shares)   (11,392) (11,392)      
Options surrendered due to employee tax liability (75)   $ (75)      
Options surrendered due to employee tax liability (shares)   (3,236) (3,236)      
Cash dividends declared (common stock, $0.22/share, $0.25/share) (7,623)         (7,623)
Net income 21,991         21,991
Change in unrealized gain (loss) on securities available for sale, net of income taxes 9,926       9,926  
Balance at end of period at Mar. 31, 2023 $ 662,165 $ 33 $ (127,603) $ 584,884 $ (79,059) $ 283,910
Ending balance, shares issued (shares) at Mar. 31, 2023   33,827,801        
Ending balance, treasury stock (shares) at Mar. 31, 2023 (3,272,514)   (3,272,514)      
Ending balance, shares outstanding (shares) at Mar. 31, 2023   30,555,287